Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Protective role against restenosis from an interleukin-1 receptor antagonist gene polymorphism in patients treated with coronary stenting

1 Dec 2000

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adipokines, Inflammation, and Metabolic Diseases
Share to Atherosclerosis and Cardiovascular Diseases
Share to Coronary Interventions and Diagnostics

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 11127457
DOI: 10.1016/s0735-1097(00)01014-7

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Protective role against restenosis from an interleukin-1 receptor antagonist gene polymorphism in patients treated with coronary stentingPMID 11127457Read ↗

Genetic risk of restenosis after percutaneous coronary interventions in the era of drug-eluting stents.Semantic proximity Read ↗

Are common leptin promoter polymorphisms associated with restenosis after coronary stenting?Semantic proximity Read ↗

Investigating the relationship between the VNTR variant of the interleukin-1 receptor antagonist gene and coronary in-stent restenosis.Semantic proximity Read ↗

Association of a CD18 gene polymorphism with a reduced risk of restenosis after coronary stenting.Semantic proximity Read ↗

The Relationships between Polymorphisms in Genes Encoding the Growth Factors TGF-β1, PDGFB, EGF, bFGF and VEGF-A and the Restenosis Process in Patients with Stable Coronary Artery Disease Treated with Bare Metal Stent.Semantic proximity Read ↗

The interleukin 1B-511 polymorphism is associated with the risk of developing restenosis after coronary stenting in Mexican patients.Semantic proximity Read ↗

The Relationship between VEGFA and TGFB1 Polymorphisms and Target Lesion Revascularization after Elective Percutaneous Coronary Intervention.Semantic proximity Read ↗

Tumor necrosis factor-alpha, lymphotoxin-alpha, and interleukin-10 gene polymorphisms and restenosis after coronary artery stenting.Semantic proximity Read ↗

Association of Lipoprotein(a) and Inflammation with In-Stent Restenosis Across Distinct Medication Adherence Phenotypes: An Exploratory Study Incorporating a "Natural Resistance" PopulationSemantic proximity Read ↗

The T29C (rs1800470) polymorphism of the transforming growth factor-β1 (TGF-β1) gene is associated with restenosis after coronary stenting in Mexican patients.Semantic proximity Read ↗

4G/5G polymorphism of the plasminogen activator inhibitor-1 gene and risk of restenosis after coronary artery stenting.Semantic proximity Read ↗

Genetic inflammatory factors predict restenosis after percutaneous coronary interventions.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.